Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of anesthesia levels of intrathecal bupivacaine injection
IRCT20190529043750N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine, sponsored by Babol University of Medical Sciences. Primary endpoint: Sensory block level. Started Jul 2021; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on IRCT20190529043750N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190529043750N3.